2022 - Research.com Best Female Scientist Award
Her primary areas of investigation include Internal medicine, Endocrinology, Insulin, Alzheimer's disease and Placebo. Her Internal medicine research is multidisciplinary, relying on both Diabetes mellitus and Naproxen. Her Endocrinology research is multidisciplinary, incorporating elements of Memory disorder and Memory impairment.
The Insulin study which covers Central nervous system that intersects with Elementary cognitive task, Saline, Laboratory rat and Memoria. Her work carried out in the field of Alzheimer's disease brings together such families of science as Gastroenterology, Celecoxib, Insulin-degrading enzyme, Rosiglitazone and Naproxen Sodium. Her studies in Placebo integrate themes in fields like Recall, Randomized controlled trial, Verbal memory, Cognition and Nasal administration.
Suzanne Craft mostly deals with Internal medicine, Endocrinology, Disease, Insulin and Cognition. Her Internal medicine study combines topics from a wide range of disciplines, such as Diabetes mellitus and Placebo. Her studies deal with areas such as Verbal memory, Cerebrospinal fluid and Recall as well as Endocrinology.
She interconnects Neuroscience, Oncology and Bioinformatics in the investigation of issues within Disease. Her Insulin research incorporates themes from Carbohydrate metabolism and Nasal administration. Her research in Cognition intersects with topics in Gerontology, Clinical psychology and Cognitive decline.
Her primary areas of study are Internal medicine, Disease, Cognition, Dementia and Endocrinology. Suzanne Craft frequently studies issues relating to Cardiology and Internal medicine. In the subject of general Cognition, her work in Montreal Cognitive Assessment is often linked to Association, thereby combining diverse domains of study.
Her Dementia research incorporates elements of Microbiome, Clinical trial, Effects of sleep deprivation on cognitive performance, Cognitive test and Alzheimer's disease. Her Alzheimer's disease study integrates concerns from other disciplines, such as Apolipoprotein E and Neuroscience. Suzanne Craft studies Blood–brain barrier, a branch of Endocrinology.
Her scientific interests lie mostly in Internal medicine, Disease, Dementia, Cognition and Alzheimer's disease. The study incorporates disciplines such as Endocrinology and Oncology in addition to Internal medicine. Her Disease study incorporates themes from Neuroimaging, White matter, Mediterranean diet and Cerebrospinal fluid.
Her Dementia research incorporates elements of Odds ratio, Placebo, Randomized controlled trial and Clinical trial. In general Cognition study, her work on Neurocognitive, Neuropsychological test and Montreal Cognitive Assessment often relates to the realm of Association, thereby connecting several areas of interest. She interconnects TREM2 and Cohort in the investigation of issues within Alzheimer's disease.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling;Paul S. Aisen;Laurel A. Beckett;David A. Bennett.
Alzheimers & Dementia (2011)
Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment
Suzanne Craft;Laura D. Baker;Thomas J. Montine;Satoshi Minoshima.
JAMA Neurology (2012)
Effects of aerobic exercise on mild cognitive impairment: a controlled trial.
Laura D. Baker;Laura L. Frank;Karen Foster-Schubert;Pattie S. Green.
JAMA Neurology (2010)
Insulin and neurodegenerative disease: shared and specific mechanisms
Suzanne Craft;G Stennis Watson.
Lancet Neurology (2004)
Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease.
M E Risner;A M Saunders;J F B Altman;G C Ormandy.
Pharmacogenomics Journal (2006)
Intranasal insulin improves cognition and modulates β-amyloid in early AD
M. A. Reger;G. S. Watson;P. S. Green;C. W. Wilkinson.
Glucose Levels and Risk of Dementia
Paul K. Crane;Rod Walker;Rebecca A. Hubbard;Ge Li.
The New England Journal of Medicine (2013)
Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype.
M.A. Reger;M.A. Reger;G.S. Watson;G.S. Watson;W.H. Frey;W.H. Frey;L.D. Baker;L.D. Baker.
Neurobiology of Aging (2006)
Decreased memory performance in healthy humans induced by stress-level cortisol treatment.
John W. Newcomer;Gregg Selke;Angela K. Melson;Tamara Hershey.
Archives of General Psychiatry (1999)
Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype.
Suzanne Craft;Elaine Peskind;Michael W. Schwartz;Gerard D. Schellenberg.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: